Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-26

FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' supplemental application for nicardipine hydrochloride, enabling the marketing of this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicardipine hydrochloride (Nicardipine)

Snippet

SUPPL AP for NICARDIPINE HYDROCHLORIDE (NICARDIPINE HYDROCHLORIDE)